A Phase I Study to Evaluate the Safety and Immunogenicity of Heterologous Boost Immunizations With MVA-CMDR
PHASE1CompletedINTERVENTIONAL
Enrollment
14
Participants
Timeline
Start Date
January 31, 2014
Primary Completion Date
May 31, 2015
Study Completion Date
May 31, 2015
Conditions
HIV
Interventions
BIOLOGICAL
MVA-CMDR
injections of MVA-CMDR vaccine
Trial Locations (1)
10065
The Rockefeller University, New York
All Listed Sponsors
lead
Rockefeller University
OTHER
NCT01889719 - A Phase I Study to Evaluate the Safety and Immunogenicity of Heterologous Boost Immunizations With MVA-CMDR | Biotech Hunter | Biotech Hunter